Pain Medicine Doctors in Tennessee Medicare Details, Address, Contact
42 Pain Medicine doctors found. Showing 41 - 42
 Mr. Chad M Galle, CRNA Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 Tyson Ave, Paris, TN 38242 Phone: 731-644-8535 |
Dr. Charles Grafford Hilgenhurst, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 519 Enon Springs Rd E, Smyrna, TN 37167 Phone: 615-223-6200 Fax: 615-223-2100 |
News Archive
Small businesses continue to mull health law's implications
NPR reports that some say the health law is having a chilling effect on hiring by small businesses. In Virginia, the Governor's Small Business Summit is focusing on what might happen once the overhaul is in full force.
Altair Therapeutics initiates its IL-4 receptor alpha inhibitor bronchoprovocation phase 2 trial
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Study finds specific direct targets for lung cancer treatment
A team of researchers at the Salk Institute has found two therapeutic targets for the deadly type of lung cancer, non-small-cell lung carcinomas (NSCLCs), which accounts for 85 percent of all lung cancer cases. They believe that the breakthrough discovery could pave the way for the development of new treatments for a majority of lung cancer patients.
NCI-funded sequencing project aims to identify genetic links to colorectal cancer
Uncovering colon cancer's genetic roots is the focus of a new $13 million, four-year, National Cancer Institute-funded project at Fred Hutchinson Cancer Research Center. Ulrike (Riki) Peters, Ph.D., M.P.H., a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort. She and her colleagues will use next-generation sequencing, a technique that captures entire genome sequences, to identify genetic links to colorectal cancer.
Decision Resources forecasts biosimilar insulins and insulin analogues to erode $6.1 billion in brand sales
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilar insulins and insulin analogues stand to erode $6.1 billion in brand sales in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018, saving healthcare systems $3.8 billion in the process.
› Verified 5 days ago